Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bio Key International (BKYI) Asset Writedowns and Impairment (2017 - 2025)

Bio Key International (BKYI) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $15000.0 as the latest value for Q1 2025.

Quarterly Asset Writedowns and Impairment fell 85.0% to $15000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$198005.0 through Sep 2025, down 118.22% year-over-year, with the annual reading at -$213005.0 for FY2024, 105.94% down from the prior year.
Asset Writedowns and Impairment hit $15000.0 in Q1 2025 for Bio Key International, up from -$213005.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $1.5 million in Q2 2023 to a low of -$213005.0 in Q4 2024.
Historically, Asset Writedowns and Impairment has averaged $484070.7 across 3 years, with a median of $100000.0 in 2024.
Biggest five-year swings in Asset Writedowns and Impairment: plummeted 119.6% in 2024 and later crashed 85.0% in 2025.
Year by year, Asset Writedowns and Impairment stood at $1.1 million in 2023, then tumbled by 119.6% to -$213005.0 in 2024, then surged by 107.04% to $15000.0 in 2025.
Business Quant data shows Asset Writedowns and Impairment for BKYI at $15000.0 in Q1 2025, -$213005.0 in Q4 2024, and -$100000.0 in Q2 2024.